How We Research, Grade Evidence & Source

Evidence & methods

How We Research, Grade Evidence & Source

Our methodology is independent and built on primary sources. We start with the original studies, weight them by quality and independence, and trace the money and relationships behind the research — so every grade reflects the evidence itself, not who is promoting it.

Evidence hierarchy

The evidence ladder

Not all evidence carries equal weight. We rank study types from strongest to weakest, and a claim's grade reflects the best available evidence supporting it.

1
Systematic reviews & meta-analyses Pool many trials to estimate an overall effect. The strongest basis for a confident conclusion.
Strongest
2
Randomised controlled trials Randomisation and control groups isolate cause and effect. High-quality primary evidence.
Strong
3
Cohort & observational studies Track outcomes in real populations. Useful for associations, but cannot prove causation.
Moderate
4
Mechanistic & animal studies Explain how something might work in cells or animals. Suggestive, but rarely conclusive in humans.
Weak
5
Expert opinion & anecdote Informed judgement and individual reports. A starting point for questions, not an answer to them.
Weakest
Our key differentiator

How we trace funding and conflicts of interest

A study's declared conflicts are only the starting point. We go beyond author self-disclosures to independently verify who paid for the research and who stands to gain from its findings.

Beyond self-disclosure

Author declarations are frequently incomplete or absent. Rather than take them at face value, we independently investigate the relationships around each study — and weight the evidence accordingly.

1
Funding sources
We identify who financed the trial — public bodies, foundations, or industry — even when it is buried or unstated.
2
Author affiliations
We check where authors work and who employs them, looking for ties that a disclosure line might omit.
3
Patents
We look for patents held on the ingredient or method being studied, which can create a direct financial stake in the result.
4
Advisory roles
Paid advisory boards, consultancies, and speaker arrangements are traced, not assumed to be declared.
5
Industry relationships
Grants, product supply, and ongoing partnerships with manufacturers are surfaced and factored into the grade.
6
Independence weighting
Where independence is unclear or an interest is found, the evidence is weighted down — and the reason is stated plainly.

Primary databases we use

Every source below is grouped by type. We link to the original wherever possible — and note where a source is used only for discovery or context.

Peer-reviewed literature

Primary databases

  • The backbone of our medical research. Every study cited links to its PubMed entry where possible.

  • Independent systematic reviews, considered the gold standard for evidence synthesis.

  • Used for discovery only; we trace back to the primary source before citing.

    Discovery only

Independent & government health

Balanced reference

Regulatory & toxicology

Safety & status

  • Regulatory status, GRAS designations, adverse event reports.

  • Herbal monographs and assessment reports.

  • EFSA

    European Food Safety Authority — safety opinions and tolerable upper intake levels.

  • Regulatory status and limits from India's food safety authority.

  • Third-party quality and contaminant testing.

    Partly paywalled

Systematic review bodies

Evidence synthesis

Adverse events & interactions

Safety signals

Nutrition databases

Composition & intake

What we exclude

What we avoid

Some sources look authoritative but carry a built-in bias or add nothing verifiable. We do not treat any of the following as evidence.

  • Press releases — written to promote a finding, not to weigh it, and often out of step with the underlying data.
  • Affiliate sites — pages that earn commission on the products they recommend have a financial reason to overstate benefits.
  • Marketing materials — brand claims, sponsored content, and product copy are advertising, not evidence.
  • Aggregator blogs — sites that restate other articles without checking the primary source, compounding any original errors.

The rule of thumb: if a claim cannot be traced back to a primary study, a systematic review, or a regulator, it does not shape our verdicts.

Limitations of our approach

  • We cannot read every study ever published; we prioritize systematic reviews and recent high-quality RCTs.
  • Evidence evolves. We date every article and revisit claims as new research emerges.
Found an error or a newer, stronger study? Contact us — we will update the article and note the change.

This methodology is itself reviewed and updated periodically. Last reviewed: July 2026.

Putting it together

For every claim we grade, we combine the evidence ladder with our funding and conflict checks. A finding built on strong, independent research earns a high grade; one resting on weak or industry-tied evidence is graded down and flagged. The result is a verdict you can trace — from the grade, to the studies, to who paid for them.

See how grades are applied to ingredients · See our full source list

Our methods are reviewed and updated as evidence standards evolve.